Great article by John Carlos Diaz on the issue of hashtag#professionalresearchsubjects and hashtag#duplicatesubjects https://lnkd.in/eJrFDDF. Use of the Verified Clinical Trials (VCT) prevents this issue at the time of screening and protects throughout the entire study. Easy to implement and cost-effective. Contact VCT at info@verifiedclinicaltrials.com or call +1.516.998.7499
Celerion & Verified Clinical Trials Prevent Duplicate Enrollment In Clinical Trials Celerion and Verified Clinical Trials share the same vision of applying scientific expertise and advanced technology to ensure the safety of our participants and maintain data integrity… GARDEN CITY, NEW YORK (PRWEB) MARCH 14, 2017 Celerion was the first early stage contract research organization (CRO) to …
GARDEN CITY, NEW YORK (PRWEB) FEBRUARY 25, 2017 The STARR Coalition today announced their partnership with Verified Clinical Trials in an ongoing effort to create meaningful change by increasing communication, partnerships and goodwill among stakeholders in the areas of treatment, advocacy, and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. Both organizations are dedicated to promoting patient …
High Point, NC (PRWEB) February 14, 2017 High Point Clinical Trials Center announced that it has partnered with Verified Clinical Trials (VCT), the global clinical trials database registry, to ensure the appropriate selection and qualification of subjects participating in their clinical trials at their North Carolina research facility. “We are extremely pleased to partner with Verified’s …
MINNEAPOLIS, MINNESOTA (PRWEB) JANUARY 19, 2017 DaVita Clinical Research (DCR), a specialty contract research organization with services spanning the full spectrum of drug and device development, and Prism Clinical Research, a leader in providing fully integrated clinical research services to pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has been selected by both companies as an exclusive provider …
Recognizing duplicate enrollment in clinical trials as an increasing threat to the viability and integrity of drug development, a leading clinical trials research site, Pillar Clinical Research has voluntarily elected to institute verification of the enrollment status for all research volunteers who are screened for their current enrolling studies. Pillar Clinical Research Selects Verified Clinical …
Segal Institute for Clinical Research has chosen Verified Clinical Trials (VCT), the global clinical trial database registry utilizing biometric fingerprint technology, to counter attempts at professional research subjects and duplicate enrollment in clinical trial research and improve the safety of research volunteers and data quality. Miami, FL (PRWEB) September 20, 2016 Segal Institute for …
With several years of experience and data, Verified Clinical Trials dispels several myths regarding professional subjects and research subject misbehavior in clinical trials research. GARDEN CITY, NEW YORK (PRWEB) AUGUST 05, 2016 Verified Clinical Trials dispels several common myths regarding duplicate enrollment in clinical trials and the issues surrounding the professional research subject. Based on 6 years of …
Marking a 6 year anniversary as the clinical trials research subject database registry Verified Clinical Trials continues their growth and expansion. GARDEN CITY, NEW YORK (PRWEB) AUGUST 02, 2016 Verified Clinical Trials continues to expand their footprint in the clinical trial community as they herald 6 years of experience stopping professional research subjects from duplicate enrollment in clinical trials. The …
GARDEN CITY, NEW YORK (PRWEB) JULY 21, 2016 Verified Clinical Trials continues to enhance their offerings and has successfully and seamlessly offered the newest technology that includes a biometrics fingerprint platform to their clients and the research community. The newest technology will improve accuracy while improving efficiencies at the site level where verifications are performed. The largest and …
